doi:10.1016/j.virs.2026.04.005

[1]
Song-Kang Qin, Kuan-Hao Li, Ben-Jin Liu, Cun Cao, De-Bin Yu, Zhi-Gang Jiang, Jun Wang, Yu-Xin Han, Fang Wang, Ying-Lin Qi, Chao Sun, Li Yu, Ji-Tao Chang, Xin Yin, 2024: Efficient and robust reverse genetics system for bovine rotavirus generation and its application for antiviral screening, Virologica Sinica, 39, 917-928. doi: 10.1016/j.virs.2024.09.010
[2]
Hao Huang, Xiaobing Lu, Tianlai Hong, Yihong Chen, Meisheng Yi, Kuntong Jia, 2026: Development of the reverse genetics system for viral hemorrhagic septicemia virus genotype IVa and its application in antiviral compound screening, Virologica Sinica, 41, 107-118. doi: 10.1016/j.virs.2025.12.010
[3]
Yudi Pan, Zixin Li, Qian Miao, Hongyan Shi, Longjun Guo, Li Feng, Jin Tian, 2025: Phylogenitc analysis and immunogenicity comparison of porcine genotype G9 rotavirus in China from 2020-2023, Virologica Sinica, 40, 176-185. doi: 10.1016/j.virs.2025.02.003
[4]
Yuzhang Sun, Mingjun Sun, Yonglian Dai, Renfu Yin, Zhuang Ding, 2016: An improved reverse genetics system for Newcastle disease virus genotype Ⅶ, Virologica Sinica, 31, 521-524. doi: 10.1007/s12250-016-3869-3
[5]
Xiaoyan Zhang, Kai Sun, Yan Liang, Chenglu Zhao, Zhenghe Li, 2021: Development of RNA Polymerase III-Driven Reverse Genetics System for the Rescue of a Plant Rhabdovirus, Virologica Sinica, 36, 1252-1255. doi: 10.1007/s12250-021-00390-y
[6]
Hou-Li Cai, Yao-Wei Huang, 2023: Reverse genetics systems for SARS-CoV-2: Development and applications, Virologica Sinica, 38, 837-850. doi: 10.1016/j.virs.2023.10.001
[7]
Xiu-Li Yan, Jian Li, Qing-Qing Ma, Hong-Jiang Wang, Lin Li, Hui Zhao, Cheng-Feng Qin, Xiao-Feng Li, 2024: Identification of mutations in viral proteins involved in cell adaptation using a reverse genetic system of the live attenuated hepatitis A virus vaccine H2 strain, Virologica Sinica, 39, 882-891. doi: 10.1016/j.virs.2024.08.004
[8]
Tolganay Kulatay, Elena Sedova, Alexander Shevtsov, Gulzat Zauatbayeva, Bakytkali Ingirbay, Viktoriya Keyer, Zhanar Shakhmanova, Maral Zhumabekova, Yergali Abduraimov, Aralbek Rsaliyev, Nurgul Sikhayeva, Irina Kozlova, Mikhail Zaripov, Alexandr V. Shustov, 2025: Synthetic genomics-based generation of the tick-borne encephalitis virus Siberian subtype prototype strain and E51K-attenuated variant for vaccine development and antiviral screening, Virologica Sinica, 40, 812-821. doi: 10.1016/j.virs.2025.09.010
[9]
Wenqi Zou, Qingchuan Yu, Yan Liu, Qingliang Li, Hong Chen, Jiamei Gao, Chen Shi, Ying Wang, Wei Chen, Xuan Bai, Biao Yang, Jiuwei Zhang, Ben Dong, Bo Ruan, Liuyifan Zhou, Gelin Xu, Zhongyu Hu, Xiaoming Yang, 2023: Genotype analysis of rotaviruses isolated from children during a phase III clinical trial with the hexavalent rotavirus vaccine in China, Virologica Sinica, 38, 889-899. doi: 10.1016/j.virs.2023.11.002
[10]
Chun-Guang Wu, Jian-Hua Wang, Bo Zhu, Jing Chen, 2026: Development of a stable replicon system of a pangolin merbecovirus for antiviral screening, Virologica Sinica, 41, 236-239. doi: 10.1016/j.virs.2026.02.004
[11]
董长垣, 胡俊, 2003: RNA Interference and Its Prospect of Application in the Effect of Antiviral Infection, Virologica Sinica, 18, 407-410.
[12]
宋岩, 师东方, 樊琛, 刘胜旺, 魏华, 李一经, 2005: Cloning of vp4 Gene from Porcine Rotavirus JL94 Isolate and Expression in Baculovirus System, Virologica Sinica, 20, 61-64.
[13]
Qiran Yin, Han Xiao, Hengrui Hu, Jiang Li, Manli Wang, Zhihong Hu, 2026: Development of an HSV-1 F strain BAC system using the synthetic platform, Virologica Sinica, 41, 478-481. doi: 10.1016/j.virs.2026.03.003
[14]
吴颖运, 洪坤学, 陈启明, 耿运琪, 邵一鸣, , 2004: Generation of Full-genome SHIV-KB9 Clone and Its Replication in Human and Monkey Peripheral Blood Mononuclear Cells*, Virologica Sinica, 19, 114-119.
[15]
汤华, 任中原, 1988: Assay for HSV-Induced Deoxythymidine Kinase and Its Application to Antiviral Compound Study, Virologica Sinica, 3, 148-.
[16]
Yun-Yun Jin, Hanwen Lin, Liu Cao, Wei-Chen Wu, Yanxi Ji, Liubing Du, Yiling Jiang, Yanchun Xie, Kuijie Tong, Fan Xing, Fuxiang Zheng, Mang Shi, Ji-An Pan, Xiaoxue Peng, Deyin Guo, 2021: A Convenient and Biosafe Replicon with Accessory Genes of SARS-CoV-2 and Its Potential Application in Antiviral Drug Discovery, Virologica Sinica, 36, 913-923. doi: 10.1007/s12250-021-00385-9
[17]
肖春惠, 杨占秋, 2001: The Development of The Hantan Virus Vaccine, Virologica Sinica, 16, 299-303.
[18]
何孔旺, 林继煌, 江杰元, 沈江萍, 黄宝顺, 李保同, 杨毓华, 1990: Preperation and Application of Monoclonal Antibodies to Bovine Rotavirus, Virologica Sinica, 5, 430-.
[19]
Hongbo Guo, Dan Liu, Kuan Liu, Yao Hou, Chunyang Li, Qiudi Li, Xiaohui Ding, Monique M. A. Verstegen, Jikai Zhang, Lingli Wang, Yibo Ding, Renxian Tang, Xiucheng Pan, Kuiyang Zheng, Luc J. W. van der Laan, Qiuwei Pan, Wenshi Wang, 2024: Drug repurposing screen identifies vidofludimus calcium and pyrazofurin as novel chemical entities for the development of hepatitis E interventions, Virologica Sinica, 39, 123-133. doi: 10.1016/j.virs.2023.11.006
[20]
罗保君, 张强, 杨茜, 丁美, 刘树玲, 杭长寿, 王海涛, 周育森*, 2004: Expression and Immunologenic Study of the Hantaan Virus Glycoprotein G1 and G2 by Using the Adenoviral Vector, Virologica Sinica, 19, 224-227.